Today: 30 April 2026
Browse Category

Stock Market 28 January 2026

Starbucks stock dips as supply-chain snags and CEO jet policy land ahead of earnings

Starbucks stock dips as supply-chain snags and CEO jet policy land ahead of earnings

Starbucks shares fell 0.6% to $95.72 Tuesday ahead of its fiscal first-quarter earnings report set for Wednesday morning. CEO Brian Niccol is under scrutiny as supply-chain issues persist despite new technology and system upgrades. The company also removed the $250,000 cap on Niccol’s personal use of the corporate jet after a security review. Wall Street analysts adjusted price targets as investors focus on sales and margins.
Carvana stock rises after Wells Fargo target hike, but options traders lean defensive

Carvana stock rises after Wells Fargo target hike, but options traders lean defensive

Carvana shares closed up 0.9% at $477.75 after volatile trading Tuesday. Wells Fargo raised its price target to $525, citing strong retail trends but flagged possible weather-related risks. Options trading showed a surge in put buying ahead of the Fed decision and Carvana’s Feb. 18 earnings. Implied volatility remained high, with puts outnumbering calls by nearly two to one.
28 January 2026
Constellation Energy stock closes higher as PJM data-center rule overhaul keeps power prices in focus

Constellation Energy stock closes higher as PJM data-center rule overhaul keeps power prices in focus

Constellation Energy closed up 1.2% at $288.76 Tuesday, after trading between $282.50 and $290.40. PJM Interconnection advanced a fast-track plan for data-center hookups and began talks on a government-backed “backstop” auction for new power capacity. Traders are watching natural-gas volatility and PJM/FERC policy moves. Constellation’s next earnings update is expected Feb. 17.
28 January 2026
Elevance Health stock gets hit by Medicare rate surprise — what traders watch before earnings

Elevance Health stock gets hit by Medicare rate surprise — what traders watch before earnings

Elevance Health shares fell 14.3% to $322.92 Tuesday after a Medicare Advantage rate proposal from CMS projected a net average payment increase of just 0.09%, far below Wall Street expectations. The move triggered a broader selloff in health insurer stocks. Investors are awaiting Elevance’s earnings report Wednesday for updates on pricing and costs. CMS will finalize policy milestones in late February and early April.
Roper Technologies stock (ROP) slides after weak 2026 outlook puts Deltek back in focus

Roper Technologies stock (ROP) slides after weak 2026 outlook puts Deltek back in focus

Roper Technologies shares dropped 9.7% to $369.27 in after-hours trading Tuesday after the company issued a 2026 profit and revenue forecast below Wall Street estimates and warned of continued weak demand at its Deltek unit. Stifel downgraded the stock, citing ongoing Deltek softness. Roper reported Q4 revenue up 10% to $2.06 billion and adjusted EPS of $5.21. The company projected 2026 adjusted EPS of $21.30–$21.55.
28 January 2026
Johnson & Johnson stock climbs after fresh FDA Darzalex Faspro nod — what investors watch next

Johnson & Johnson stock climbs after fresh FDA Darzalex Faspro nod — what investors watch next

Johnson & Johnson shares rose 1.3% Tuesday after the FDA approved a Darzalex Faspro combination for newly diagnosed multiple myeloma patients ineligible for stem-cell transplants. The S&P 500 closed at a record high, while healthcare stocks broadly fell after a Medicare payment proposal. The U.S. also named 15 drugs for future Medicare price negotiations, increasing pressure on big pharma.
KLA stock jumps nearly 5% as analysts lift targets ahead of Jan. 29 earnings

KLA stock jumps nearly 5% as analysts lift targets ahead of Jan. 29 earnings

KLA shares rose 4.8% to about $1,616 in after-hours trading Tuesday after Evercore ISI and Wolfe Research raised price targets ahead of Thursday’s earnings. The company projects fiscal Q2 revenue of $3.225 billion and non-GAAP EPS of $8.70, with Zacks’ consensus slightly higher. KLA warned U.S.-China trade tensions could cut sales by up to $350 million over the next five quarters.
Applied Digital stock jumps after Nvidia’s $2 billion CoreWeave bet — what to watch next

Applied Digital stock jumps after Nvidia’s $2 billion CoreWeave bet — what to watch next

Applied Digital shares jumped 14.2% in after-hours trading Tuesday, closing at $41.35 after Nvidia invested $2 billion in CoreWeave, Applied’s major client. The stock saw heavy volume, with 47.5 million shares traded. Applied Digital relies on long-term leases with CoreWeave at its North Dakota campus, expected to generate $11 billion in revenue.
Mastercard stock price slips after Agent Suite AI launch as earnings near

Mastercard stock price slips after Agent Suite AI launch as earnings near

Mastercard shares fell 1.3% to $520.41 Tuesday, underperforming the S&P 500, as investors awaited Thursday’s earnings report. The company launched “Mastercard Agent Suite,” a set of AI-powered business tools, set for release in the second quarter. Trading volume was above average. Cantor Fitzgerald began coverage with an “Overweight” rating.
Bloom Energy stock pops after hours as Jefferies lifts target, earnings next up

Bloom Energy stock pops after hours as Jefferies lifts target, earnings next up

Bloom Energy shares jumped 9% to $152.31 in after-hours trading Tuesday after a volatile session with over 13 million shares traded. Jefferies raised its price target to $92 but kept an Underperform rating, citing new orders but warning on high valuation. Investors await Bloom’s Feb. 5 results for updates on capacity and deployment schedules.
RTX stock jumps after earnings beat, 2026 outlook; tariffs and defense orders in focus

RTX stock jumps after earnings beat, 2026 outlook; tariffs and defense orders in focus

RTX shares rose 3.7% to $201.28 in after-hours trading Tuesday after the company posted a 12% jump in fourth-quarter sales to $24.2 billion and issued a 2026 outlook above some forecasts. Jet-engine demand and aircraft repairs drove growth, while defense spending stayed steady. RTX projected 2026 adjusted sales of $92–93 billion and free cash flow of $8.25–8.75 billion. Investors are watching tariffs and new defense policy changes.

Stock Market Today

  • Straumann Starts 2026 with Strong Organic Growth, Reaffirms Guidance
    April 30, 2026, 3:26 AM EDT. Straumann Holding AG reported first-quarter revenue of CHF 673 million, driven by 7.1% organic growth despite a 1.2% decline in Swiss franc terms due to currency effects. Growth was led by implantology and digital solutions, including intraoral scanners and the AXS platform. Strong regional performances came from EMEA, Latin America, and North America, with Asia-Pacific growth excluding China normalisation. The firm advanced its implantology lead through the iEXCEL system and Neodent expansion. Management reaffirmed its 2026 outlook for high single-digit organic revenue growth and modest core EBIT margin improvement, showing confidence amid currency challenges and macroeconomic volatility. The stock currently holds a Sell rating with a CHF 83 price target.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 30.04.2026

30 April 2026
OCBC will pay a total dividend of S$0.58 per share in May, including a S$0.16 special dividend. UOB declared a final dividend of S$0.71 per share despite lower net interest income. ST Engineering reported higher revenue and profit, with a S$0.23 per share dividend. Jardine Matheson raised its annual dividend 4% to US$2.35 per share, payable mid-May.
Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Go toTop